tiprankstipranks

Kevin T Crofton Insider Profile

4 Followers
Kevin T Crofton, Director at Creo Medical, holds 18.78M shares in Creo Medical (Ticker: GB:CREO), holds 4.36M shares in DC Two Ltd. (Ticker: AU:AI1). Most recently, Kevin T Crofton Bought ― shares of Creo Medical on May 22, 2026 for an estimated value of 2.00M .
tipranks
Kevin T Crofton

Kevin T Crofton
Creo Medical (CREO)
Director

Ranked #11,635 out of 107,686 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

+33.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

AU$6M
75.96%
24.04%
A breakdown of Kevin T Crofton's holdings

Insider Roles

Creo Medical
(CREO)
Director
DC Two Ltd.
(AI1)
Director
Roles that Kevin T Crofton holds in companies

Most Profitable Insider Trade

Stock:
DC Two Ltd.
(AI1)
Rating:Informative Buy
Date:May 19, 2025 - May 19, 2026
Return:+266.00%
The most profitable trade made by Kevin T Crofton

Kevin T Crofton's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Creo Medical
May 22, 2026
Director
Informative Buy
2.00M
£2.62M
DC Two Ltd.
Jan 12, 2026
Director
Uninformative Buy
AU$828.96K
List of latest transactions for each holding click on a transaction to see Kevin T Crofton's performance on stock

Kevin T Crofton insider profile FAQ

What is the percentage of profitable transactions made by Kevin T Crofton?
The percentage of profitable transactions made by Kevin T Crofton is 33%.
    What is the average return per transaction made by Kevin T Crofton?
    The average return per transaction made by Kevin T Crofton is 33.10%.
      What stocks does Kevin T Crofton hold?
      Kevin T Crofton holds: GB:CREO, AU:AI1 stocks.
        What was Kevin T Crofton’s latest transaction?
        Kevin T Crofton latest transaction was an Informative Buy of 2.00M .
          What was Kevin T Crofton's most profitable transaction?
          Kevin T Crofton’s most profitable transaction was an Informative Buy of AU:AI1 stock on May 19, 2025. The return on the trade was 266.00%.
            What is Kevin T Crofton's role in Creo Medical?
            Kevin T Crofton's role in Creo Medical is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.